Press Releases about HUTCHMED (China) Limited - American Depositary Shares



HUTCHMED to Announce 2024 Final Results
February 19, 2025
Via GlobeNewswire



Via GlobeNewswire





HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
November 21, 2024
Via GlobeNewswire






HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
September 24, 2024
Via GlobeNewswire





HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia
August 21, 2024
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.